ADVERTISEMENT
ADVERTISEMENT
site_logo
  • Campus
  • Happening
  • Opinion
  • People
  • News
  • #BeInspired
  • Careers
  • 40 under 40
  • Exams
  • What The FAQ
  • Videos
    • Straight Up
    • Odisha Literary Festival 2020
    • Campus Convo
    • Careers After Corona
    • Express Expressions
    • Q&A With Prabhu Chawla
    • ThinkEdu Awards 2020
  • Web Stories
  • edex_worksEDEXWORKS
ADVERTISEMENT

Published: 21st September 2020     

Central Institute of Brackishwater Aquaculture's bacteria-eating virus tech now available to shrimp farms

According to ICAR-CIBA, bacteriophages and their lytic enzymes are in use for therapy of bacterial infections in human and animals, as bio-control agents for food protection 

Edex Live
Edex Live
f_icon t_icon i_icon l_icon koo_icon whatsapp_icon email_icon Google News

Share Via Email

Central-Institute-Brackishwater-Aquaculture-Chennai-min

CIBA

The ICAR-Central Institute of Brackishwater Aquaculture (CIBA) on Monday said it has transferred its technology to make bacteriophages, or viruses that eat bacteria, to control bacterial diseases in shrimp hatcheries. The ICAR-CIBA signed an MoU with Salem Microbes Private Ltd, Salem to transfer the technology to enable production of quality shrimp seeds, free of antibiotics. ICAR-CIBA Director K.K. Vijayan said that their product comprises a "cocktail of phages" which can neutralise a wide range of pathogenic bacteria-causing diseases.

This helps in replacing the use of antibiotics which, according to him, pose the concern of residues and antimicrobial resistance. Salem Microbes CEO Ramesh Kumar Dhanakoti said his company, which focuses on exploitation of microbes for improved farming productivity and environmental quality, is keen to partner with the ICAR-CIBA in scaling up phage technology for the benefit of the aquaculture sector.

The 'phage prophylaxis and therapy' developed by the research institute is based on bacteriophages which are viruses that kill only specific disease-causing bacteria and act as therapeutic agents in controlling bacterial infections. Unlike in the case of antibiotics, bacteriophage therapy has no residual issues and has advantages of being specific to their host bacteria without harming other micro-organisms, the ICAR-CIBA said.

"In aquaculture hatcheries, bacterial diseases like vibriosis often cause considerable economic loss to hatchery operators across the globe. CIBA's new product will be of great use in preventing and controlling such diseases in aquaculture, especially in shrimp hatcheries," said S. V. Alavandi, its Principal Scientist and Head of Aquatic Animal Health and Environment Division. "A broad spectrum of lytic bacteriophages from aquaculture system and coastal ecosystem of India used for the formulation of the product which was proved its efficacy in field evaluation trials," he said. According to ICAR-CIBA, bacteriophages and their lytic enzymes are in use for therapy of bacterial infections in human and animals, as bio-control agents for food protection as well as tools in molecular biology.

telegram

O
P
E
N

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
telegram
ADVERTISEMENT
Write to us!

If you have campus news, views, works of art, photos or just want to reach out to us, just drop us a line.

newsletter_icon
Mailbox
edexlive@gmail.com
fb_icon
Facebook
twitter_icon
Twitter
insta_icon
Instagram
ADVERTISEMENT
Facebook
ADVERTISEMENT
Tweets by Xpress_edex
ADVERTISEMENT
ADVERTISEMENT

FOLLOW US

The New Indian Express | The Morning Standard | Dinamani | Kannada Prabha | Samakalika Malayalam | Cinema Express | Indulgexpress | Events Xpress

Contact Us | About Us | Privacy Policy | Terms of Use

Home | Live Now | Live Story | Campus Trip | Coach Calling | Live Take

Copyright - edexlive.com 2023. All rights reserved. Website Designed, Developed & Maintained by Express Network Private Ltd.